Journal of Ophthalmology / 2020 / Article / Tab 2

Research Article

Efficacy and Safety Outcomes of Intravitreal Dexamethasone Implant Therapy for the Treatment of Adult Coats’ Disease

Table 2

Baseline clinical characteristics of patients with Stage 3A Coats’ disease.

Case no.Age/genderSystemic diseasePrior treatmentBCVA (logMAR)CRT (μm)IOP (mmHg)Retinal details at first visit

Case 141/maleFatty liver diseaseIntravitreal ganciclovir1.055212.8Exudative retinal detachment
Case 252/maleNoneIVC, laser1.422810Subtotal ERD with massive exudates
Case 359/maleNoneNone1.85149213.9Subtotal ERD with massive exudates and epiretinal membrane
Case 440/maleNoneLaser1.85211113Subtotal ERD with subretinal hemorrhage
Case 545/maleNoneIVR1.373214.2Extensive peripheral retinal vascular telangiectasia
Case 647/femaleNoneNone0.370715Subtotal ERD with massive exudates
Case 736/maleNoneNone0.564016Considerable exudation involving the posterior pole
Case 846/femaleNoneNone0.229113Subtotal ERD with massive exudates
Case 934/maleNoneIVC, laser1.8529013Subtotal ERD with massive exudates
Case 1042/maleDiabeticNone0.531015.9Subtotal ERD with massive exudates

BCVA: best-corrected visual acuity. logMAR: 10 logarithm of minimum angle of resolution letters. CRT: central retinal thickness. IOP: intraocular pressure. DEX: dexamethasone intravitreal implant. IVC: intravitreal injection of conbercept. PPV: pars plana vitrectomy. ERD: exudative retinal detachment.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.